Literature DB >> 6868953

Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients.

I S Neu.   

Abstract

Statistical evaluation of essential fatty acids (determined by gas chromatography) in the serum and cerebrospinal fluid of patients with definite MS and acute CCT showed marked differences as compared to healthy subjects. It was also evident that the decrease of essential fatty acids in MS patients differed from that of CCT patients. Whereas the fatty acid levels in the serum of MS patients revealed only minor differences as compared to the controls and CCT patients, MS patients did show a clear decrease, especially of linoleic and arachidonic acids, in the CSF. This difference was most pronounced in cholesterol esters in the CSF. One absorption study with safflower oil demonstrated normal enteral absorption of essential fatty acids and the ability to cross the blood-CSF barrier.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6868953     DOI: 10.1111/j.1600-0404.1983.tb04558.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter.

Authors:  R Wilson; D R Tocher
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

2.  Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

Authors:  Mariana Vaini de Freitas; Marcela Ramos de Oliveira; Diogo Fernandes dos Santos; Rita de Cássia Mascarenhas Netto; Sheila Bernardino Fenelon; Nilson Penha-Silva
Journal:  J Membr Biol       Date:  2010-02-10       Impact factor: 1.843

3.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Nutritional factors and aging in demyelinating diseases.

Authors:  Ana M Adamo
Journal:  Genes Nutr       Date:  2013-12-06       Impact factor: 5.523

Review 5.  [Diet and multiple sclerosis].

Authors:  S Schwarz; H Leweling
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

6.  A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.

Authors:  D Bates; N E Cartlidge; J M French; M J Jackson; S Nightingale; D A Shaw; S Smith; E Woo; S A Hawkins; J H Millar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

7.  Omega-3 fatty acids and multiple sclerosis: relationship to depression.

Authors:  Robin L Aupperle; Douglas R Denney; Sharon G Lynch; Susan E Carlson; Debra K Sullivan
Journal:  J Behav Med       Date:  2008-04

8.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

9.  Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.

Authors:  William R Wikoff; Gurudutt Pendyala; Gary Siuzdak; Howard S Fox
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 10.  Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Authors:  Francisco J Quintana; Ada Yeste; Howard L Weiner; Ruxandra Covacu
Journal:  J Neuroimmunol       Date:  2012-05-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.